Synthetic drugs : scope and trends in synthetic cannabinoids and stimulants /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Gray, Terrence L., Evans, Sage F.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hauppauge, N.Y. : Lancaster : Nova Science ; Gazelle [distributor], 2012.
Colección:Substance abuse assessment, interventions and treatment.
Drug transit and distribution, interception and control.
Temas:
Designer drugs.
Designer Drugs
Drogues de confection.
MEDICAL > Pain Medicine.
MEDICAL > Psychiatry > Psychopharmacology.
Designer drugs
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocn844975955
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 130529s2012 nyua ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d E7B  |d YDXCP  |d OCLCF  |d EBLCP  |d OCLCQ  |d D6H  |d AGLDB  |d OCLCQ  |d VTS  |d INT  |d AU@  |d OCLCQ  |d STF  |d OCLCQ  |d M8D  |d OCLCQ  |d AJS  |d OCLCQ  |d OCLCO  |d INARC  |d OCLCQ  |d OCLCO 
020 |a 9781620818268  |q (electronic bk.) 
020 |a 1620818264  |q (electronic bk.) 
020 |z 9781620818138 
020 |z 1620818132 
029 1 |a AU@  |b 000062325634 
029 1 |a DEBBG  |b BV042796259 
029 1 |a DEBSZ  |b 472788272 
035 |a (OCoLC)844975955 
050 4 |a RM316 
072 7 |a MED  |x 093000  |2 bisacsh 
072 7 |a MED  |x 105020  |2 bisacsh 
082 0 4 |a 615.78  |2 23 
049 |a UAMI 
245 0 0 |a Synthetic drugs :  |b scope and trends in synthetic cannabinoids and stimulants /  |c Terrence L. Gray and Sage F. Evans, editors. 
260 |a Hauppauge, N.Y. :  |b Nova Science ;  |a Lancaster :  |b Gazelle [distributor],  |c 2012. 
300 |a 1 online resource (xi, 122 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Substance abuse assessment, interventions and treatment 
490 1 |a Drug transit and distribution, interception and control 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a SYNTHETIC DRUGS: SCOPE AND TRENDS IN SYNTHETIC CANNABINOIDS AND STIMULANTS; SYNTHETIC DRUGS: SCOPE AND TRENDS IN SYNTHETIC CANNABINOIDS AND STIMULANTS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: SYNTHETIC DRUGS: OVERVIEW AND ISSUES FOR CONGRESS; SUMMARY; BACKGROUND ON SYNTHETIC AND DESIGNER DRUGS; SCHEDULING OF SYNTHETIC DRUGS: CONTROLLED SUBSTANCES ACT; CURRENT TRENDS IN SELECTED SYNTHETICS; SELECTED LEGISLATION IN THE 112TH CONGRESS; ISSUES; Chapter 2: STATEMENT OF SENATOR DIANNE FEINSTEIN. HEARING ON ''DANGEROUS SYNTHETIC DRUGS"" 
505 8 |a Chapter 3: STATEMENT OF SENATOR CHARLES GRASSLEY. HEARING ON "DANGEROUS SYNTHETIC DRUGS"Chapter 4: STATEMENT OF JOSEPH RANNAZZISI, DEA DEPUTY ASSISTANT ADMINISTRATOR. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; INTRODUCTION; SITUATIONAL OVERVIEW; CURRENT EFFORTS AND CHALLENGES -- TEMPORARY SCHEDULING AND PROSECUTION UNDER THE ANALOGUE STATUTE; CONCLUSION; Chapter 5: STATEMENT OF ERICA LEARY, PROGRAM MANAGER, NORTH COASTAL PREVENTION COALITION. HEARING ON"DANGEROUS SYNTHETIC DRUGS"; THE IMPACT OF SYNTHETIC MARIJUANA IN SAN DIEGO COUNTY; ACCESS, AVAILABILITY, AND PROMOTION. 
505 8 |a EFFORTS UNDERTAKEN TO COMBAT THE PROBLEMHOW THE COMBATING DANGEROUS DESIGNER DRUGS ACT OF 2011 WILL HELP COMMUNITIES; WHY COMMUNITY COALITIONS ARE KEYS TO SUCCESS; Chapter 6: STATEMENT OF MIKE ROZGA. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; Chapter 7: AFFIDAVIT OF ANTHONY SCALZO, MD. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; Chapter 8: SYNTHETIC CANNABINOIDS AND SYNTHETIC CATHINONES REPORTED IN NFLIS, 2009-2010; HIGHLIGHTS; INTRODUCTION; NATIONAL AND REGIONAL ESTIMATES; SYNTHETIC CANNABINOIDS AND SYNTHETICCATHINONES, BY STATE IN NFLIS, 2010; NATIONAL POISON CONTROL CENTER DATA. 
505 8 |a APPENDIX. CHEMICAL NAMES OF SYNTHETIC CANNABINOIDS AND SYNTHETIC CATHINONESChapter 9: NIDA INFOFACTS: SPICE; HOW IS SPICE ABUSED?; EXTENT OF USE; WHAT ARE THE HEALTH EFFECTS OF SPICE ABUSE?; OTHER INFORMATION SOURCES; RESOURCES; Chapter 10: JWH-018 1-PENTYL-3-(1-NAPHTHOYL) INDOLE [SYNTHETIC CANNABINOID IN HERBAL PRODUCTS]; INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY; ILLICIT USES; USER POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 11: JWH-073 1-BUTYL-3-(1-NAPHTHOYL) INDOLE [SYNTHETIC CANNABINOID IN HERBAL PRODUCTS]; INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY. 
505 8 |a ILLICIT USESUSER POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 12: 3,4-METHYLENEDIOXYPYROVALERONE (MDPV); INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY; USER POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 13: NIDA INFOFACTS: METHAMPHETAMINE; HOW IS METHAMPHETAMINE ABUSED?; HOW DOES METHAMPHETAMINE AFFECT THE BRAIN?; WHAT OTHER ADVERSE EFFECTS DOES METHAMPHETAMINE HAVE ON HEALTH?; WHAT TREATMENT OPTIONS EXIST?; HOW WIDESPREAD IS METHAMPHETAMINE ABUSE?; OTHER INFORMATION SOURCES; REFERENCES; Chapter 14: NIDA INFOFACTS: MDMA (ECSTASY); HOW IS MDMA ABUSED? 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Designer drugs. 
650 2 |a Designer Drugs 
650 6 |a Drogues de confection. 
650 7 |a MEDICAL  |x Pain Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Psychiatry  |x Psychopharmacology.  |2 bisacsh 
650 7 |a Designer drugs  |2 fast 
700 1 |a Gray, Terrence L. 
700 1 |a Evans, Sage F. 
776 0 8 |i Print version:  |t Synthetic drugs.  |d Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012  |z 9781620818138  |w (OCoLC)834070198 
830 0 |a Substance abuse assessment, interventions and treatment. 
830 0 |a Drug transit and distribution, interception and control. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=581786  |z Texto completo 
938 |a Internet Archive  |b INAR  |n syntheticdrugssc0000unse 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3022225 
938 |a ebrary  |b EBRY  |n ebr10698272 
938 |a EBSCOhost  |b EBSC  |n 581786 
938 |a YBP Library Services  |b YANK  |n 10712520 
994 |a 92  |b IZTAP 

Ejemplares similares